PROCEPT BioRobotics (PRCT) Stock Analysis: AI Score & Alternative Data
PRCT alt-data: revenue climbing, job postings lagging
Is PROCEPT BioRobotics a buy right now? The alternative data says hold. This PRCT stock analysis is built on the 25+ alternative data signals AltIndex tracks on PROCEPT BioRobotics every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 47/100: a Hold. The stock trades at $18.45 with a $997M market cap.
The bullish side of the 90-day ledger: revenue up 12.5% YoY to $90M. The drag: job postings down 59.4% to 26 open roles, and web traffic down 6.0% to 10K monthly visits. That tension is what keeps the score mid-range.
PRCT’s broader alt-data profile also covers headcount (898 employees, according to LinkedIn), X followers (2K), and sentiment (100/100). Every signal links to its own page with full history, the PRCT technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on PRCT is just below.
PROCEPT BioRobotics AI Stock Analysis
PROCEPT BioRobotics is a medical device company pioneering the use of image-guided robotic systems in urology. The company's flagship product, AquaBeam Robotic System, is used to perform minimally invasive prostate surgeries.
Analysis generated October 3, 2026.
Recent PROCEPT BioRobotics Stock Alerts
|
PROCEPT BioRobotics | October 14 Price is down by -6.3% in the last 24h. |
|
PROCEPT BioRobotics | October 12 Price is up by 6.1% in the last 24h. |
|
PROCEPT BioRobotics | October 1 Price is down by -6.4% in the last 24h. |
|
PROCEPT BioRobotics | September 29 Price is up by 7.7% in the last 24h. |
PROCEPT BioRobotics Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 10K | 6.0% | |
| Job Posts | 26 | 59.4% | |
| LinkedIn Employees | 898 | 0.8% | |
| Sentiment | 100 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 68 | 1,033.3% | |
| Stocktwits Mentions | 4 | 50.0% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 1K | 0.7% | |
| 4chan Mentions | 0 | N/A | |
| X Followers | 2K | 0% |
About PROCEPT BioRobotics (PRCT)
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH).
| Price | $18.45 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $997M |
| Year Range | $17 – $37 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Medical Devices |
Latest PROCEPT BioRobotics News
View more → |
PROCEPT BioRobotics (NASDAQ: PRCT) Investors: Securities Class Action Filed; Shareholders Should Contact Shareholders FoundationOctober 1 - PRNewswire |
PROCEPT BioRobotics Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PRCTSeptember 22 - PRNewswire |
|
 |
PRCT Deadline: PRCT Investors with Losses in Excess of $100K Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud LawsuitSeptember 21 - PRNewswire |
 |
PRCT FINAL DEADLINE ALERT: PROCEPT BioRobotics Corporation Investors Alerted to September 22, 2026 Lead Plaintiff Deadline in Securities Fraud Class Action LawsuitSeptember 21 - PRNewswire |
 |
TUESDAY PRCT INVESTOR DEADLINE: PROCEPT BioRobotics Corporation Investors with Substantial Losses Have Opportunity to Lead the PROCEPT Class Action LawsuitSeptember 18 - PRNewswire |
See PROCEPT BioRobotics’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for PRCT, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEPROCEPT BioRobotics Earnings & Financial Performance
View all earnings →PROCEPT BioRobotics Insider Trading Activity
View all →| Templin Barry L filed to sell 94,826 shares at $0.0. Sep 9 '26 |
| Nouri Alaleh filed to sell 127,737 shares at $0.0. Sep 9 '26 |
| Waters Kevin filed to sell 180,355 shares at $0.0. Sep 9 '26 |
| Wood Larry L filed to sell 23,900 shares at $0.0. Aug 7 '26 |
| Templin Barry L filed to sell 68,953 shares at $0.0. Jun 8 '26 |
PROCEPT BioRobotics Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to PROCEPT BioRobotics
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Integra LifesciencesIART |
$13.71 1.3% | $1B | 37 |
 |
ArtivionAORT |
$21.74 0.6% | $1B | 48 |
 |
BioventusBVS |
$13.73 0.6% | $922M | 62 |
 |
Tandem Diabetes CareTNDM |
$16.79 1.6% | $1B | 38 |
 |
Avanos MedicalAVNS |
$24.99 0.0% | $1B | 43 |
Explore PROCEPT BioRobotics Data
Frequently Asked Questions: PROCEPT BioRobotics (PRCT)
PROCEPT BioRobotics has an AltIndex AI Score of 47/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
47/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of PROCEPT BioRobotics (PRCT) stock is $18.45 with a market cap of $997M.
As of today, PROCEPT BioRobotics’s PE (Price to Earnings) ratio is —.
View the latest PROCEPT BioRobotics insider transactions to see recent buying and selling activity by company executives and directors.
Check the PROCEPT BioRobotics congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The PRCT stock price chart above shows PROCEPT BioRobotics’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full PROCEPT BioRobotics technical analysis for RSI, moving averages, and more.
See the stocks similar to PROCEPT BioRobotics section on this page for companies in the same industry ranked by market cap and AI Score.
